Search

​On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...

The Fundamentals of Arbitration Are you dealing with a dispute and debating whether to resolve it through arbitration pursuant to an arbitration provision in the subject agreement? Are you considering adding an arbitration provision to your standard contracts? This webinar will provide you with the...

Recent Cases Interpreting the Federal Arbitration Act: Badgerow v. Walters & More! Litigation Associate Stephanie Denker will join a panel and discuss important decisions impacting arbitration waivers, petitions to confirm arbitral awards under 9 U.S.C. §9 and petitions to vacate arbitral awards...